Oya Alpar

594 total citations
21 papers, 482 citations indexed

About

Oya Alpar is a scholar working on Pharmaceutical Science, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Oya Alpar has authored 21 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmaceutical Science, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Oya Alpar's work include Advanced Drug Delivery Systems (8 papers), Inhalation and Respiratory Drug Delivery (7 papers) and RNA Interference and Gene Delivery (4 papers). Oya Alpar is often cited by papers focused on Advanced Drug Delivery Systems (8 papers), Inhalation and Respiratory Drug Delivery (7 papers) and RNA Interference and Gene Delivery (4 papers). Oya Alpar collaborates with scholars based in United Kingdom, Egypt and Australia. Oya Alpar's co-authors include Satyanarayana Somavarapu, Rihab Osman, Nahed D. Mortada, Gehanne A.S. Awad, Abd-Elhameed EL-Shamy, Pei Kan, Dorothea Sesardic, Sevda Şenel, Xiongwei Li and John A. Hersey and has published in prestigious journals such as PLoS ONE, Biomaterials and Journal of Materials Chemistry.

In The Last Decade

Oya Alpar

21 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oya Alpar United Kingdom 14 216 125 110 100 60 21 482
Koushlesh Ranjan India 11 61 0.3× 130 1.0× 18 0.2× 140 1.4× 116 1.9× 39 559
Indu Singh India 11 122 0.6× 190 1.5× 22 0.2× 92 0.9× 90 1.5× 40 606
Zeynep Mustafaeva Türkiye 13 62 0.3× 233 1.9× 13 0.1× 101 1.0× 19 0.3× 44 499
K.S. Jaganathan India 13 471 2.2× 345 2.8× 108 1.0× 119 1.2× 104 1.7× 20 852
Upendra P. Lambe India 8 43 0.2× 80 0.6× 26 0.2× 90 0.9× 74 1.2× 16 350
Melahat Bağırova Türkiye 14 42 0.2× 130 1.0× 25 0.2× 93 0.9× 27 0.5× 39 674
Nicholas Mank United States 8 58 0.3× 215 1.7× 23 0.2× 17 0.2× 53 0.9× 11 472
Wouter F. Tonnis Netherlands 13 193 0.9× 192 1.5× 152 1.4× 19 0.2× 73 1.2× 15 555
Dagmar Petsch Germany 8 47 0.2× 349 2.8× 49 0.4× 52 0.5× 28 0.5× 8 644
Ana Camila Oliveira Souza United States 15 75 0.3× 143 1.1× 31 0.3× 37 0.4× 347 5.8× 25 608

Countries citing papers authored by Oya Alpar

Since Specialization
Citations

This map shows the geographic impact of Oya Alpar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oya Alpar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oya Alpar more than expected).

Fields of papers citing papers by Oya Alpar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oya Alpar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oya Alpar. The network helps show where Oya Alpar may publish in the future.

Co-authorship network of co-authors of Oya Alpar

This figure shows the co-authorship network connecting the top 25 collaborators of Oya Alpar. A scholar is included among the top collaborators of Oya Alpar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oya Alpar. Oya Alpar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alpar, Oya, et al.. (2014). Impact of surfactant selection on the formulation and characterization of microparticles for pulmonary drug delivery. Drug Development and Industrial Pharmacy. 41(3). 522–528. 6 indexed citations
3.
Shaw, Andrew E., Anke Brüning‐Richardson, Ewan E. Morrison, et al.. (2013). Bluetongue virus infection induces aberrant mitosis in mammalian cells. Virology Journal. 10(1). 319–319. 4 indexed citations
4.
Osman, Rihab, Khuloud T. Al‐Jamal, Gehanne A.S. Awad, et al.. (2013). Inhalable DNase I microparticles engineered with biologically active excipients. Pulmonary Pharmacology & Therapeutics. 26(6). 700–709. 20 indexed citations
5.
Osman, Rihab, Pei Kan, Gehanne A.S. Awad, et al.. (2013). Spray dried inhalable ciprofloxacin powder with improved aerosolisation and antimicrobial activity. International Journal of Pharmaceutics. 449(1-2). 44–58. 59 indexed citations
6.
Jabbar, Tamara, Eva Calvo-Pinilla, Simon Gubbins, et al.. (2013). Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2. PLoS ONE. 8(4). e60574–e60574. 44 indexed citations
7.
Osman, Rihab, Pei Kan, Gehanne A.S. Awad, et al.. (2011). Enhanced properties of discrete pulmonary deoxyribonuclease I (DNaseI) loaded PLGA nanoparticles during encapsulation and activity determination. International Journal of Pharmaceutics. 408(1-2). 257–265. 16 indexed citations
8.
Wang, Yiwei, Jenny K.W. Lam, Xiongwei Li, et al.. (2010). Biomechanical Characterization of a Micro/Macroporous Polycaprolactone Tissue Integrating Vascular Graft. Cardiovascular Engineering and Technology. 1(3). 202–215. 3 indexed citations
9.
Florindo, Helena F., et al.. (2009). Antibody and cytokine-associated immune responses to S. equi antigens entrapped in PLA nanospheres. Biomaterials. 30(28). 5161–5169. 30 indexed citations
10.
Somavarapu, Satyanarayana, et al.. (2009). TMC–MCC (N-trimethyl chitosan–mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines. European Journal of Pharmaceutical Sciences. 38(4). 362–369. 68 indexed citations
11.
Alpar, Oya, et al.. (2008). Development and testing of particulate formulations for the nasal delivery of antibodies. Journal of Controlled Release. 135(2). 127–135. 26 indexed citations
12.
Colonna, C., Bice Conti, Ida Genta, & Oya Alpar. (2008). Non-viral dried powders for respiratory gene delivery prepared by cationic and chitosan loaded liposomes. International Journal of Pharmaceutics. 364(1). 108–118. 29 indexed citations
13.
Grassi, Gabriele, Rossella Farra, Dario Voinovich, et al.. (2007). Characterization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices. Journal of Drug Delivery Science and Technology. 17(5). 325–331. 19 indexed citations
14.
Somavarapu, Satyanarayana, et al.. (2005). Effect of Vitamin E TPGS on immune response to nasally delivered diphtheria toxoid loaded poly(caprolactone) microparticles. International Journal of Pharmaceutics. 298(2). 344–347. 31 indexed citations
15.
Atuah, Kwame N., et al.. (2004). Cationic stearylamine-containing biodegradable microparticles for DNA delivery. Journal of Microencapsulation. 21(1). 25–36. 17 indexed citations
16.
Smith, Anthony W., Jane Wilton, Stuart Clark, et al.. (1991). Production and characterization of monoclonal antibodies to outer membrane proteins of Pseudomonas aeruginosa grown in iron-depleted media. Microbiology. 137(2). 227–236. 8 indexed citations
17.
Alpar, Oya, et al.. (1990). Preliminary studies on infection by attenuated Salmonella in guinea pig and on expression on herpes simplex virus. Research in Microbiology. 141(7-8). 873–877. 9 indexed citations
18.
Alpar, Oya, et al.. (1981). The in vitro incorporation and release of hydroxocobalamin by liposomes. International Journal of Pharmaceutics. 7(4). 349–351. 16 indexed citations
19.
Alpar, Oya, John A. Hersey, & E Shotton. (1970). The compression properties of lactose. Journal of Pharmacy and Pharmacology. 22(Supplement_1). 1S–7S. 18 indexed citations
20.
Alpar, Oya, et al.. (1969). The possible use of polytetrafluoroethylene (Fluon) as a tablet lubricant. Journal of Pharmacy and Pharmacology. 21(Supplement_1). 6S–8S. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026